CEPT1

Across TCGA pan-cancer cohorts, CEPT1 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of CEPT1’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where CEPT1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types CEPT1 is over-expressed in tumor, although a few such as PDAC and OV show the opposite, repressed pattern.

CCRCC, PDAC, and COAD are the cancer types where CEPT1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CEPT1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Male	II,III,IV	+0.382	<.001	11	view →
PDAC	Male	All	−0.924	<.001	6	view →
COAD	Female	All	+0.188	<.001	6	view →
OV	All	All	−0.326	.046	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

CEPT1–CCRCC

Open the CCRCC breakdown →